Edition: BP 2025 (Ph. Eur. 11.6 update)<\/p>\n
Action and use <\/strong><\/p>\n Antihelminthic.<\/p>\n Oxyclozanide Oral Suspension is an aqueous suspension of Oxyclozanide containing suitable suspending and dispersing agents.<\/p>\n The oral suspension complies with the requirements stated under Oral Liquids and with the following requirements.<\/em><\/p>\n Content of oxyclozanide, C13<\/sub>H6<\/sub>Cl5<\/sub>NO3<\/sub><\/p>\n 95.0 to 105.0% of the stated amount.<\/p>\n In test A for Related substances the principal spot in the chromatogram obtained with 10 \u00b5L of solution (1) corresponds to that in the chromatogram obtained with solution (3).<\/p>\n Related substances<\/strong><\/p>\n A. Carry out the method for thin-layer chromatography, Appendix III A, using silica gel G as the coating substance and a mixture of 5 volumes of glacial acetic acid, 20 volumes of acetone and 60 volumes of petroleum spirit (boiling range, 60\u00b0 to 80\u00b0) as the mobile phase. Apply separately to the plate 40 \u00b5L and 10 \u00b5L of solution (1), 4 \u00b5L of solution (2) and 10 \u00b5L of solution (3). For solution (1) dilute the oral suspension with acetone to contain 1.0% w\/v of Oxyclozanide, centrifuge and use the supernatant liquid. Solution (2) contains 0.050% w\/v of 3,5,6-trichloro-2-hydroxybenzoic acid BPCRS in acetone. Solution (3) contains 1.0% w\/v of oxyclozanide BPCRS in acetone. After removal of the plate, allow it to dry in air and spray with a 3.0% w\/v solution of iron(III) chloride hexahydrate in methanol. In the chromatogram obtained with 40 \u00b5L of solution (1) any spot corresponding to 3,5,6-trichloro-2-hydroxybenzoic acid is not more intense than the spot in the chromatogram obtained with solution (2) (0.5%).<\/p>\n B. Carry out the method for thin-layer chromatography, Appendix III A, using silica gel G as the coating substance and a mixture of 1 volume of 13.5M ammonia as the mobile phase, 10 volumes of methanol and 100 volumes of ethyl acetate. Apply separately to the plate 40 \u00b5L of solution (1) and 4 \u00b5L of solution (2). For solution (1) dilute the oral suspension with acetone to contain 1.0% w\/v of Oxyclozanide, centrifuge and use the supernatant liquid. Solution (2) contains 0.050% w\/v of 2-amino-4,6-dichlorophenol hydrochloride BPCRS in acetone. After removal of the plate, allow it to dry in air and spray with phosphomolybdotungstic reagent . In the chromatogram obtained with solution (1) any spot corresponding to 2-amino-4,6-dichlorophenol is not more intense than the spot in the chromatogram obtained with solution (2) (0.4%).<\/p>\n Protect the solutions from light throughout the Assay. To a quantity of the oral suspension containing 60 mg of Oxyclozanide add 60 mL of acidified methanol and boil gently on a water bath. Shake continuously for 20 minutes, cool to 2\u00b0 and dilute to 100 mL with acidified methanol. Filter, dilute 5 mL of the filtrate to 100 mL with acidified methanol and measure the absorbance of the resulting solution at the maximum at 300 nm, Appendix II B. Calculate the content of C13<\/sub>H6<\/sub>Cl5<\/sub>NO3<\/sub> taking 254 as the value of A(1%, 1 cm) at the maximum at 300 nm.<\/p>\n","protected":false},"excerpt":{"rendered":" Edition: BP 2025 (Ph. Eur. 11.6 update) Action and use Antihelminthic. DEFINITION Oxyclozanide Oral Suspension is an aqueous suspension of Oxyclozanide containing suitable suspending and dispersing agents. The oral suspension complies with the requirements stated under Oral Liquids and with the following requirements. Content of oxyclozanide, C13H6Cl5NO3 95.0 to 105.0% of the stated amount. IDENTIFICATION…<\/p>\n","protected":false},"author":5,"featured_media":24696,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[176],"tags":[],"class_list":["post-24695","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-british-pharmacopoeia-veterinary-2020"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/24695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=24695"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/24695\/revisions"}],"predecessor-version":[{"id":24708,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/24695\/revisions\/24708"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/24696"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=24695"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=24695"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=24695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}DEFINITION<\/h2>\n
IDENTIFICATION<\/h2>\n
ASSAY<\/h2>\n